Immunohistochemical Expression of Epidermal Growth Factor Receptor in Hepatocellular Carcinoma

1. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74–108.10.3322/canjclin.55.2.7415761078Search in Google Scholar

2. Hashem B. El-Serag. Hepatocellular Carcinoma. N Engl J Med 2011; 365: 1118–1127 DOI: 10.1056/NEJMra100168310.1056/NEJMra100168321992124Open DOISearch in Google Scholar

3. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557–2576.10.1053/j.gastro.2007.04.06117570226Search in Google Scholar

4. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World Journal of Gastroenterology : WJG. 2008; 14(27):4 300–4308. doi:10.3748/wjg.14.4300.10.3748/wjg.14.4300273118018666317Open DOISearch in Google Scholar

5. Ramakrishna G, Rastogi A, Trehanpati N, Sen B, Khosla R, Sarin SK. From Cirrhosis to Hepatocellular Carcinoma: New Molecular In sights on Inflammation and Cellular Senescence. Liver Cancer. 2013; 2(3–4): 367–383. doi:10.1159/000343852.10.1159/000343852388131924400224Open DOISearch in Google Scholar

6. Gilgenkrantz H, de l’Hortet AC. New insights into liver regeneration. Clin Res Hepatol Gastroenterol. 2011; 35: 623–9. DOI:10.1016/j.clinre.2011.04.002.10.1016/j.clinre.2011.04.00221613004Open DOISearch in Google Scholar

7. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol. 2012; 57: 692–4. DOI:10.1002/hep.20969.10.1002/hep.2096916447274Open DOISearch in Google Scholar

8. Berasain C, Avila MA. The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. J Gastroenterol. 2014 Jan; 49(1): 9-23. doi: 10.1007/s00535-013-0907-x.10.1007/s00535-013-0907-x24318021Open DOISearch in Google Scholar

9. Gea VH, Toffanin S, Friedman SL, Llovet JM. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology. 2013; 144(3): 512–27.10.1053/j.gastro.2013.01.002357806823313965Search in Google Scholar

10. Nikolaou K, Sarris M, Talianidis I. Molecular pathways: the complex roles of inflammation pathways in the development and treatment of liver cancer. Clin Cancer Res. 2013; 1(19): 2810–6.10.1158/1078-0432.CCR-12-196123549874Search in Google Scholar

11. Capece D, Fischietti M, Verzella D, Gaggiano A, Cicciarelli G, Tessitore A, et al. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int. 2013; 2013: 187204.10.1155/2013/187204359118023533994Search in Google Scholar

12. Zhang DY, Friedman SL. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology. 2012; 56: 769–75.10.1002/hep.25670408715922378017Open DOISearch in Google Scholar

13. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006 Jan 17; 366(1): 2–16.10.1016/j.gene.2005.10.01816377102Search in Google Scholar

14. Hirsh FR, Varella-Garcia M, Cappuzzo F. Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer. Oncogene2009; 28: S32–S37. Doi:10.1038/onc.2009.199.10.1038/onc.2009.19919680294Open DOISearch in Google Scholar

15. Hanawa M, Suzuki S, Dobashi Y, Yamane T, Kono K, Enomoto N, Ooi A. EGFR protein over-expression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer. 2006 Mar 1; 118(5): 1173–80.10.1002/ijc.2145416161046Search in Google Scholar

16. Kira S, Nakanishi T, Suemori S, Kitamoto M, Watanabe Y, Kajiyama G. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma. Liver. 1997; 17: 177–82. PMID: 929848710.1111/j.1600-0676.1997.tb00803.x9298487Search in Google Scholar

17. Breuhahn K, Longerich T, Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene. 2006;26(25): 3787–800. DOI: 10.1038/sj.onc.120955610.1038/sj.onc.120955616799620Open DOISearch in Google Scholar

18. Qin LX, Tang ZY. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 193–199. PMID:11925590.10.3748/wjg.v8.i2.193465834911925590Search in Google Scholar

19. Zhu AX, Rosmorduc O, Evans J.T.R., Ross PJ, Santoro A, Carrilho FJ, et al. SEARCH: A Phase III, Randomized, Double-Blind,Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma. J Clin Oncol 2015; 33: 559–566.10.1200/JCO.2013.53.774625547503Search in Google Scholar

20. Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti K3, Batra SK. Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012 January; 16(1): 15–31. doi:10.1517/14728222.2011.648617.10.1517/14728222.2011.648617329178722239438Open DOISearch in Google Scholar

21. Wu X and Li Y. Signaling Pathways in Liver Cancer, in Alexander Julianov. Liver Tumors. IntechOpen, February 3rd 2012. DOI: 10.5772/31381. Available from: https://www.intechopen.com/books/liver-tumors/signaling-pathways-in-liver-cancer.10.5772/31381.Availablefrom:https://www.intechopen.com/books/liver-tumors/signaling-pathways---Open DOISearch in Google Scholar

22. Berasain C, Ujue Latasa M, Urtasun R, Goñi S, Elizalde M, Garcia-Irigoyen O, et al. Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer. Cancers (Basel). 2011 May 18; 3(2): 2444–61. doi: 10.3390/cancers3022444.10.3390/cancers3022444Open DOISearch in Google Scholar

23. Jorissen R.N, Walker F, Pouliot, N, Garrett T.P, Ward C.W, Burgess A.W. Epidermal growth factor receptor: Mechanisms of activation and signalling. Exp. Cell Res. 2003; 284, 31–53.10.1016/S0014-4827(02)00098-8Search in Google Scholar

24. Citri A, Yarden Y. EGF-ErbB signalling: Towards the systems level. Nat. Rev. Mol. Cell Biol. 2006; 7, 505–516.10.1038/nrm1962Open DOISearch in Google Scholar

25. Schneider M.R, Wolf E. The epidermal growth factor receptor ligands at a glance. J. Cell. Physiol. 2009; 218, 460–466.10.1002/jcp.21635Search in Google Scholar

26. Komposch K, Sibilia M. EGFR Signaling in Liver Diseases. Int J Mol Sci. 2015 Dec 29; 17(1). pii: E30. doi: 10.3390/ijms17010030.10.3390/ijms17010030Open DOISearch in Google Scholar

27. Carver RS, Stevenson MC, Scheving LA, Russell WE. Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology. 2002; 123: 2017–27.10.1053/gast.2002.37060Search in Google Scholar

28. Berasain C, Perugorrıa MJ, Latasa MU, Castillo J, Goni S, Santamaría M, et al. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood). 2009; 234: 713–25.10.3181/0901-MR-12Search in Google Scholar

29. Komuves LG, Feren A, Jones AL, Fodor E. Expression of epidermal growth factor and its receptor in cirrhotic liver disease. J Histochem Cytochem. 2000 Jun; 48(6): 821–30. DOI:10.1177/002215540004800610.10.1177/002215540004800610Open DOISearch in Google Scholar

30. Qiao Q, Zhang J, Wang W, Li Q. Over expression of transforming growth factor-alpha and epidermal growth factor receptor in human hepatic cirrhosis tissues. Hepatogastroenterology. 2008 Jan-Feb; 55(81): 169–72. PMID:18507100.Search in Google Scholar

31. Mantovani A, Allavena P, Sica A, BalkwillF. Cancer-related inflammation. Nature 2008; 454: 436–444 doi:10.1038/nature07205.10.1038/07205Open DOISearch in Google Scholar

32. Uslu S, Kirimlioglu H, Ince U. Analysis of Epidermal Growth Factor Receptor Expression in Hepatocellular Carcinoma: A Comparision of Fluorescence in Situ Hybridization and Immunochemistry. J Gastroenterol Hepatol Res 2014; 3(8): 1193–1197 URL: http://www.ghrnet.org/index.php/joghr/article/view/815.Search in Google Scholar

33. Ito Y, Takeda T, Sakon M, Tsujimoto M, Higashiyama S, Noda K et al. Expression and clinical significance of ErbB receptor family in hepatocellular carcinoma. Br. J. Cancer 2001; 84, 1377–1383. DOI:10.1054/bjoc.2000.1580.10.1054/bjoc.2000.1580Open DOISearch in Google Scholar

34. Daveau M, Scotte M, Francois A, Coulouarn C, Ros G, Tallet Y, et al. Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Mol. Carcinogenes. 2003; 36, 130–141. doi.org/10.1002/mc.10103.10.1002/mc.10103Open DOISearch in Google Scholar

35. DeCicco LA, Kong J, Ringer DP.Carcinogen-induced alteration in liver epidermal growth factor receptor distribution during the promotion stage of hepatocarcinogenesis in rat. Cancer Lett. 1997 Jan 1; 111(1–2): 149–56.10.1016/S0304-3835(96)04524-7Search in Google Scholar

36. Panvichian R, Tantiwetrueangdet A, Sornmayura P, Leelaudomlipi S. Missense Mutations in Exons 18–24 of EGFR in Hepatocellular Carcinoma Tissues. BioMed Research International,Volume 2015, Article ID 171845, 7 pages http://dx.doi.org/10.1155/2015/17184510.1155/2015/171845457598526436086Open DOISearch in Google Scholar

37. Ali R, Wendt MK. The paradoxa functions of EGFR during breast cancer progression. Signal Transduction and Targeted Therapy, volume 2 Article number: 16042 (2017) doi:10.1038/sigtrans.2016.42.10.1038/sigtrans.2016.42539711928435746Open DOISearch in Google Scholar

38. Whittaker S, Marais R, Zhu AX.The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 2010 Sep 9; 29(36): 4989–5005. doi: 10.1038/onc.2010.236. Epub 2010 Jul 19.10.1038/onc.2010.236.Epub2010Jul19Open DOISearch in Google Scholar

39. Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK.Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012 Jan; 16(1): 15–31. doi: 10.1517/14728222.2011.648617. Epub 2012 Jan 12.10.1517/14728222.2011.648617.Epub201212Open DOISearch in Google Scholar

40. Eggert T, Greten TF. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma. Digestion. 2017; 96(1): 1-4. doi: 10.1159/000464282. Epub 2017 Jun 13.2860574510.1159/000464282.Epub201713Search in Google Scholar